Ischemic and Bleeding Outcomes According to the Academic Research Consortium High Bleeding Risk Criteria in All Comers Treated by Percutaneous Coronary Interventions

High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: the PENDULUM registry

(2021) Masato Nakamura et al.   EuroIntervention

Prevalence of the Academic Research Consortium for High Bleeding Risk Criteria and Prognostic Value of a Simplified Definition

(2020) Katsuya Miura et al.   CIRCULATION JOURNAL

Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients

(2020) Davide Cao et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

‘Ten commandments’ for the 2018 ESC/EACTS Guidelines on Myocardial Revascularization

(2019) Franz-Josef Neumann et al.   EUROPEAN HEART JOURNAL

Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting

(2019) Francesco Costa et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk

(2019) Philip Urban et al.   EUROPEAN HEART JOURNAL

Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention

(2019) Masahiro Natsuaki et al.   Circulation-Cardiovascular Interventions

Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO‐Kyoto Thrombotic and Bleeding Risk Scores

(2018) Masahiro Natsuaki et al.   Journal of the American Heart Association

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

(2017) Marco Valgimigli et al.   EUROPEAN HEART JOURNAL

Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials

(2017) Francesco Costa et al.   LANCET

Correction to: Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

(2016)   CIRCULATION

Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention

(2016) Robert W. Yeh et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents

(2016) Usman Baber et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Balancing the risks of bleeding and stent thrombosis: A decision analytic model to compare durations of dual antiplatelet therapy after drug-eluting stents

(2015) Pallav Garg et al.   AMERICAN HEART JOURNAL

Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction

(2015) Robert W. Yeh et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents

(2014) Laura Mauri et al.   NEW ENGLAND JOURNAL OF MEDICINE

A New Score for Risk Stratification of Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

(2012) Tullio Palmerini et al.   JACC-Cardiovascular Interventions

Development and Validation of a Stent Thrombosis Risk Score in Patients With Acute Coronary Syndromes

(2012) George D. Dangas et al.   JACC-Cardiovascular Interventions

Standardized Bleeding Definitions for Cardiovascular Clinical Trials

(2011) Roxana Mehran et al.   CIRCULATION

Incidence of Bleeding in ‘Real-Life’ Acute Coronary Syndrome Patients Treated with Antithrombotic Therapy

(2008) Jette Mortensen et al.   CARDIOLOGY